Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Shiffman

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
Digestive Diseases (Basel, Switzerland)|May 1, 1995
Transjugular intrahepatic portosystemic shunt: a medical perspectiveA J Sanyal, M L Shiffman
The American Journal of Gastroenterology|September 11, 1998
Nonsteroidal antiinflammatory drugs and gallstone disease: will an aspirin a day keep the gallstones away?R K Sterling, M L Shiffman
Clinics in Liver Disease|April 9, 2001
Benign recurrent intrahepatic cholestasisV A Luketic, M L Shiffman
The American Journal of Medicine|June 17, 1998
Metformin-induced acute hepatitisM M Babich, I Pike, M L Shiffman
The Journal of Laboratory and Clinical Medicine|October 1, 1992
In vivo studies of biliary ceftriaxone excretion and solubility in guinea pig hepatic bileP P Purdum, M L Shiffman, E W Moore
Antiviral Research|December 15, 2000
Alpha interferon combined with ribavirin potentiates proliferative suppression but not cytokine production in mitogenically stimulated human lymphocytesM L Shiffman, S B Verbeke, P M Kimball
Gastrointestinal Endoscopy|July 1, 1994
Risk of bleeding after endoscopic biopsy or polypectomy in patients taking aspirin or other NSAIDSM L Shiffman, M T Farrel, Y S Yee
Gastroenterology|November 1, 1990
Human gallbladder mucosal function. Effect of concentration and acidification of bile on cholesterol and calcium solubilityM L Shiffman, H J Sugerman, E W Moore
Gastroenterology|December 1, 1990
Pathogenesis of ceftriaxone-associated biliary sludge. In vitro studies of calcium-ceftriaxone binding and solubilityM L Shiffman, F B Keith, E W Moore
Gastroenterology|October 1, 1994
Flumazenil for hepatic coma: the elusive wake-up call?R K Sterling, M L Shiffman, M L Schubert
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Digestive Diseases (Basel, Switzerland)|May 1, 1995
Transjugular intrahepatic portosystemic shunt: a medical perspectiveA J Sanyal, M L Shiffman
The American Journal of Gastroenterology|September 11, 1998
Nonsteroidal antiinflammatory drugs and gallstone disease: will an aspirin a day keep the gallstones away?R K Sterling, M L Shiffman
Clinics in Liver Disease|April 9, 2001
Benign recurrent intrahepatic cholestasisV A Luketic, M L Shiffman
The American Journal of Medicine|June 17, 1998
Metformin-induced acute hepatitisM M Babich, I Pike, M L Shiffman
The Journal of Laboratory and Clinical Medicine|October 1, 1992
In vivo studies of biliary ceftriaxone excretion and solubility in guinea pig hepatic bileP P Purdum, M L Shiffman, E W Moore
Antiviral Research|December 15, 2000
Alpha interferon combined with ribavirin potentiates proliferative suppression but not cytokine production in mitogenically stimulated human lymphocytesM L Shiffman, S B Verbeke, P M Kimball
Gastrointestinal Endoscopy|July 1, 1994
Risk of bleeding after endoscopic biopsy or polypectomy in patients taking aspirin or other NSAIDSM L Shiffman, M T Farrel, Y S Yee
Gastroenterology|November 1, 1990
Human gallbladder mucosal function. Effect of concentration and acidification of bile on cholesterol and calcium solubilityM L Shiffman, H J Sugerman, E W Moore
Gastroenterology|December 1, 1990
Pathogenesis of ceftriaxone-associated biliary sludge. In vitro studies of calcium-ceftriaxone binding and solubilityM L Shiffman, F B Keith, E W Moore
Gastroenterology|October 1, 1994
Flumazenil for hepatic coma: the elusive wake-up call?R K Sterling, M L Shiffman, M L Schubert
Pageof 10